Inhibitors of oncogene signaling pathways such as STAT3 involved in development and progression of head and neck squamous cell carcinomas (HNSCC) have been screened by measuring nuclear morphology and anti-pSTAT3-Y705 antibody staining [30]. The gene discussed is STAT3; the disease is head and neck squamous cell carcinoma.